GEXVal Stock

GEXVal is to help patients and families fighting against orphan and intractable diseases

Sign up today and learn more about GEXVal Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About GEXVal Stock

GEXVal is a research and development-oriented drug discovery company. The company specializes in the creation of treatments for rare and incurable diseases. The mission of GEXVal is to provide patients and families with the rare and incurable diseases with innovative, cost-effective treatment options that will enhance their health and quality of life.

Funding History

July 2018$410M
September 2021$700M
December 2023$450M

Management

Research Alliance, Chief, Co-Founder

Takako Naito

Director Chief Knowledge Officer

Ojima Mami

President and CEO

Juran Kato

Director

Makoto Shimazaki

Chief Science Officer and Co-Founder

Lili Mao

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo